Estradiol Patch, Extended Release
Product Images NDC 0781-7129

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Estradiol (NDC 0781-7129). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

Chemical structure of estradiol, the active ingredient in Estradiol transdermal patches by Sandoz Inc. The structure shows the characteristic four-ring steroid backbone with hydroxyl groups at specific positions.*

FDA Label Image

Image 02

Estradiol transdermal patch by Sandoz Inc, an extended-release patch with visible adhesive and backing layers. The image shows the patch's textured surface and multiple layers, without visible text or strength indication. The patch is designed for dermal application.*

FDA Label Image

Image 03

A line graph displaying the concentration (pg/mL) of estradiol over time in days, for varying dosages of the estradiol transdermal patch. The dosages shown are 0.0375 mg/day, 0.05 mg/day, 0.075 mg/day, and 0.1 mg/day, with concentration values plotted on the y-axis and time on the x-axis over a period of 4 days.*

FDA Label Image

Image 04

Bar graph showing mean (SD) reduction from baseline comparing Estradiol 0.0375 mg/day patch to placebo over 12 weeks. Data for Weeks 4, 8, and 12 display greater reduction for estradiol versus placebo with statistically significant differences indicated. Sample sizes per group are also shown.*

FDA Label Image

Image 05

A line graph depicting the percentage change from baseline over treatment duration in weeks (26, 52, 78, 104) for estradiol extended-release transdermal patches at 0.1 mg/day, 0.05 mg/day, 0.0375 mg/day, 0.025 mg/day doses, and placebo. The graph shows trends for each dose compared to placebo over time.*

FDA Label Image

Image 06

A line graph showing percent change from baseline over treatment duration in weeks (26, 52, 78, 104) for Estradiol patches at 0.1 mg/day, 0.05 mg/day, 0.0375 mg/day, 0.025 mg/day, and placebo. Data markers differentiate each treatment group with statistical significance (p<0.05) indicated for comparisons involving placebo at specified weeks.*

FDA Label Image

Image 07

This text panel from the Estradiol Transdermal System provides instructions for patch application, specifying the days on which to change the patch. The days are paired as Sun/Wed, Mon/Thu, Tue/Fri, Wed/Sat, Thu/Sun, Fri/Mon, and Sat/Tue, guiding consistent use of the transdermal patch system.*

FDA Label Image

Image 08

An instructional illustration showing a hand applying a small rectangular transdermal patch to the lower abdominal area, demonstrating the correct site for placement of the Estradiol extended-release patch.*

FDA Label Image

Image 09

An instructional line drawing depicting the torso of a human body, likely indicating an application site for the Estradiol transdermal patch. The image shows the side profile of a chest and abdomen, illustrating where to place the patch on the skin.*

FDA Label Image

Image 10

An instructional line drawing depicting a person peeling the protective backing off a transdermal patch. The image shows two hands holding the patch and the backing being carefully removed, illustrating proper handling before application.*

FDA Label Image

Image 11

Illustration showing hands applying or handling a transdermal patch, demonstrating the proper way to peel or prepare the patch for use.*

FDA Label Image

Image 12

An instructional illustration showing a hand applying a small, rectangular transdermal patch to the skin of the lower abdomen, demonstrating the application method for a transdermal estradiol patch.*

FDA Label Image

Image 13

An instructional illustration showing two hands applying a transdermal patch onto the skin, demonstrating the correct placement and application technique for a patch dosage form.*

FDA Label Image

Image 14

An instructional line drawing showing a person using hands to remove the backing from a transdermal patch, likely to demonstrate how to apply a patch."}*

FDA Label Image

Image 15

Illustration showing the application of a transdermal estradiol patch on the skin of the hand, indicating the typical placement site for the estradiol patch extended-release dosage form.*

FDA Label Image

Image 16

An instructional illustration showing a hand applying a small rectangular estradiol transdermal patch to the lower abdomen of a person. The patch is positioned on the skin, indicating the method of application for the extended-release estradiol patch.*

FDA Label Image

Image 17

Packaging label for Estradiol Transdermal System delivering 0.025 mg/day, a prescription hormone patch by Sandoz Inc. The label shows it is a transdermal extended-release patch with usage instructions and includes 8 systems for twice weekly use.*

FDA Label Image

Image 18

Packaging label for Estradiol Transdermal System patch, delivering 0.0375 mg/day. The label details include the proprietary name Estradiol, dosage form as an extended release transdermal patch, and labeler Sandoz Inc. The carton indicates it contains 8 systems for twice weekly use, with instructions for patch application and removal visible on the label.*

FDA Label Image

Image 19

Packaging label for Estradiol Transdermal System patch, delivering 0.075 mg/day. The label indicates it is a prescription human drug by Sandoz Inc, includes 8 patches, and is used twice weekly. The label also provides printed instructions for patch application and removal.*

FDA Label Image

Image 20

The packaging label for Estradiol transdermal system patch, delivering 0.05 mg per day. The label shows the product name, dosage form as patch extended release for transdermal use, and the labeler Sandoz Inc. It includes instructions for use and a package count indicating that 4 systems are included, to be worn weekly.*

FDA Label Image

Image 21

Packaging label for Estradiol transdermal system delivering 0.1 mg/day by Sandoz Inc. The image shows the folded carton layout with printed instructions and product information. It mentions extended release and transdermal route, indicating a skin patch dosage form with twice-weekly application.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.